InsiderTrades.com logo

RPHM Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 17.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Reneo Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Reneo Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Reneo Pharmaceuticals Share Price & Price History

Current Price: $1.82
Price Change: +0.30 (1.20%)
As of 10/4/2024 01:00 AM ET

This chart shows the closing price history over time for RPHM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Reneo Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/24/2024Braden Michael LeonardMajor ShareholderBuy29,600$1.41$41,736.003,388,649View SEC Filing Icon  
9/17/2024Braden Michael LeonardMajor ShareholderBuy55,300$1.36$75,208.003,358,243View SEC Filing Icon  
8/13/2024Braden Michael LeonardMajor ShareholderBuy171,339$1.39$238,161.212,843,533View SEC Filing Icon  
5/14/2024Braden Michael LeonardMajor ShareholderBuy414,281$1.54$637,992.742,672,194View SEC Filing Icon  
8/28/2023Ashley HallInsiderSell15,625$6.28$98,125.0039,600View SEC Filing Icon  
6/23/2023Holdings A/S NovoMajor ShareholderSell100,000$7.10$710,000.003,330,337View SEC Filing Icon  
5/8/2023Niall O'donnellDirectorBuy125,000$8.00$1,000,000.002,188,713View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Reneo Pharmaceuticals (NASDAQ:RPHM)

90.98% of Reneo Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RPHM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Reneo Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC214,499$0.37M0.0%+6.7%0.642%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC1,025,668$1.74M0.2%N/A3.068%Search for SEC Filing on Google Icon
11/14/2024Vestal Point Capital LP799,400$1.36M0.1%+46.7%2.391%Search for SEC Filing on Google Icon
11/5/2024BML Capital Management LLC3,457,395$5.88M3.5%+29.4%10.342%Search for SEC Filing on Google Icon
9/16/2024Point72 Asia Singapore Pte. Ltd.18,027$27K0.0%N/A0.054%Search for SEC Filing on Google Icon
8/20/2024Nantahala Capital Management LLC547,804$0.85M0.0%N/A1.639%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.18,027$27K0.0%N/A0.054%Search for SEC Filing on Google Icon
8/12/2024Highbridge Capital Management LLC2,915,376$4.40M0.1%+6.5%8.723%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC442,200$0.67M0.0%-25.5%1.323%Search for SEC Filing on Google Icon
5/7/2024Marquette Asset Management LLC73,770$0.12M0.0%N/A0.221%Search for SEC Filing on Google Icon
5/2/2024Fifth Lane Capital LP32,635$54K0.0%-18.4%0.098%Search for SEC Filing on Google Icon
4/23/2024BML Capital Management LLC2,177,913$3.62M2.4%+65.7%6.517%Search for SEC Filing on Google Icon
2/15/2024Octagon Capital Advisors LP2,250,000$3.60M0.6%-1.3%6.754%Search for SEC Filing on Google Icon
2/14/2024Pale Fire Capital SE30,100$48K0.0%+102.7%0.090%Search for SEC Filing on Google Icon
2/14/2024Vestal Point Capital LP400,000$0.64M0.1%N/A1.201%Search for SEC Filing on Google Icon
2/12/2024Highbridge Capital Management LLC1,121,704$1.80M0.1%N/A3.367%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC25,315$41K0.0%N/A0.076%Search for SEC Filing on Google Icon
1/30/2024BML Capital Management LLC1,314,229$2.10M1.6%N/A3.945%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC22,097$35K0.0%N/A0.066%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.65,000$0.50M0.0%N/A0.192%Search for SEC Filing on Google Icon
11/14/2023Eventide Asset Management LLC2,078,142$15.83M0.3%+18.8%6.148%Search for SEC Filing on Google Icon
11/14/2023Pale Fire Capital SE14,851$0.11M0.0%N/A0.044%Search for SEC Filing on Google Icon
11/7/2023Dorsey Wright & Associates3,673$28K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC78,118$0.60M0.0%+5.7%0.231%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp35,963$0.27M0.0%+13.1%0.106%Search for SEC Filing on Google Icon
9/8/2023Tucker Asset Management LLC36,753$0.24M0.1%N/A0.109%Search for SEC Filing on Google Icon
8/14/2023Great Point Partners LLC1,083,317$7.11M1.4%+796.3%3.218%Search for SEC Filing on Google Icon
8/11/2023Franklin Resources Inc.1,345,145$8.82M0.0%+230.0%3.996%Search for SEC Filing on Google Icon
8/11/2023ExodusPoint Capital Management LP555,316$3.64M0.0%+125.9%1.650%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.4,659$31K0.0%N/A0.014%Search for SEC Filing on Google Icon
8/4/2023Carlyle Group Inc.2,698,957$17.68M0.6%+30.1%8.019%Search for SEC Filing on Google Icon
8/2/2023MAI Capital Management66,487$0.44M0.0%+24.4%0.198%Search for SEC Filing on Google Icon
6/1/2023Prelude Capital Management LLC14,800$89K0.0%N/A0.044%Search for SEC Filing on Google Icon
5/16/2023Great Point Partners LLC120,864$0.72M0.1%N/A0.481%Search for SEC Filing on Google Icon
5/11/2023ExodusPoint Capital Management LP245,787$1.47M0.0%+77.3%0.979%Search for SEC Filing on Google Icon
5/10/2023MAI Capital Management53,428$0.32M0.0%+96.2%0.213%Search for SEC Filing on Google Icon
5/8/2023Federated Hermes Inc.78,390$0.47M0.0%-2.0%0.312%Search for SEC Filing on Google Icon
5/5/2023Carlyle Group Inc.2,073,957$12.24M0.4%N/A8.259%Search for SEC Filing on Google Icon
2/15/2023Tang Capital Management LLC30,587$71K0.0%N/A0.125%Search for SEC Filing on Google Icon
2/9/2023MAI Capital Management27,232$63K0.0%-56.9%0.111%Search for SEC Filing on Google Icon
2/1/2023Bank of Montreal Can33,500$80K0.0%N/A0.137%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC37,640$0.13M0.0%-11.2%0.153%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC71,930$0.24M0.0%+33.3%0.294%Search for SEC Filing on Google Icon
9/16/2022Federated Hermes Inc.30,000$80K0.0%+76.5%0.123%Search for SEC Filing on Google Icon
5/4/2022Commonwealth Equity Services LLC22,347$65K0.0%N/A0.091%Search for SEC Filing on Google Icon
5/4/2022Tybourne Capital Management HK Ltd.700,000$2.06M0.1%-6.7%2.862%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd13,482$0.12M0.0%N/A0.055%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp63,547$0.54M0.0%+7.7%0.260%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd13,482$0.12M0.0%N/A0.055%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.294,281$2.19M0.0%+1.5%1.206%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Reneo Pharmaceuticals logo
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company's lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.
Read More on Reneo Pharmaceuticals

Today's Range

Now: $1.82
Low: $1.68
High: $1.90

50 Day Range

MA: $1.64
Low: $1.31
High: $1.82

52 Week Range

Now: $1.82
Low: $0.98
High: $9.21

Volume

437,523 shs

Average Volume

250,384 shs

Market Capitalization

$60.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.21

Who are the company insiders with the largest holdings of Reneo Pharmaceuticals?

Reneo Pharmaceuticals' top insider shareholders include:
  1. Braden Michael Leonard (Major Shareholder)
Learn More about top insider investors at Reneo Pharmaceuticals.